Quotient Clinical has completed its first clinical program in Japanese healthy volunteers using its Translational Pharmaceutics platform. Bridging studies conducted outside of Japan ensure that drugs that are to be marketed in Japan have been thoroughly evaluated in the Japanese population.   This program was a first-in-human investigation, performed on behalf of a U.S. sponsor, and is a four part clinical study designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynam...